Literature DB >> 29907510

Reducing X-ray imaging for proton postmastectomy chest wall patients.

Estelle Batin1, Nicolas Depauw2, Rachel B Jimenez2, Shannon MacDonald2, Hsiao-Ming Lu2.   

Abstract

PURPOSE: Proton postmastectomy radiation therapy (PMRT) patients are positioned daily using surface imaging with additional x-ray imaging for confirmation. This study aims to investigate whether weekly x-ray imaging with daily surface imaging, as performed for photon treatment, is sufficient to maintain PMRT patient positioning fidelity. METHODS AND MATERIALS: Calculated radiographic corrections and surface imaging residual setup errors were analyzed at the treatment angle for 28 PMRT patients (with and without breast implant, left and right sided). The temporal repartition of radiographic translations >3 mm occurring after surface imaging positioning was studied as well as their impact on the final patient position, defined as the comparison between the treatment angle surface image and the planning computed tomography scan. To compare both sets of images, the traditional bony anatomy landmarks on the digitally reconstructed radiographs were replaced by 3 radiopaque markers placed over the patient's skin tattoos. The temporal variation of the distances between these skin markers was analyzed, as were the surface imaging statistics.
RESULTS: Discrepancies between surface imaging and x-ray imaging were more frequent for patients without breast implants and among reconstructed patients with large implants. One-quarter of studied patients exhibited calculated radiographic translations >3 mm during the last week of treatment. In most circumstances, applying radiographic corrections did not affect patient position, which remained within 3 mm/2° robustness tolerances. One patient's implant shifted following computed tomography planning; this shift would not have been detected without x-ray imaging.
CONCLUSION: Initial and weekly x-ray acquisition combined with daily surface imaging seems adequate both for routine PMRT positioning and to monitor potential changes in the treatment area. The limits of the surface imaging system, however, need to be better specified among patients without breast implants or in those with large implant reconstructions.
Copyright © 2018 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29907510     DOI: 10.1016/j.prro.2018.03.002

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  6 in total

1.  Arms positioning in post-mastectomy proton radiation: Feasibility and development of a new arms down contouring atlas.

Authors:  Nicolas Depauw; Estelle Batin; Andrew Johnson; Shannon M MacDonald; Rachel B Jimenez
Journal:  Phys Imaging Radiat Oncol       Date:  2020-05-26

Review 2.  Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.

Authors:  Julia M Pakela; Antje Knopf; Lei Dong; Antoni Rucinski; Wei Zou
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

Review 3.  Particle Therapy for Breast Cancer.

Authors:  Roman O Kowalchuk; Kimberly S Corbin; Rachel B Jimenez
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

4.  Feasibility of surface guided radiotherapy for patient positioning in breast radiotherapy versus conventional tattoo-based setups- a systematic review.

Authors:  Wesley Naidoo; Michelle Leech
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2022-04-16

Review 5.  AAPM task group report 302: Surface-guided radiotherapy.

Authors:  Hania A Al-Hallaq; Laura Cerviño; Alonso N Gutierrez; Amanda Havnen-Smith; Susan A Higgins; Malin Kügele; Laura Padilla; Todd Pawlicki; Nicholas Remmes; Koren Smith; Xiaoli Tang; Wolfgang A Tomé
Journal:  Med Phys       Date:  2022-03-15       Impact factor: 4.506

Review 6.  Recent advanced in Surface Guided Radiation Therapy.

Authors:  P Freislederer; M Kügele; M Öllers; A Swinnen; T-O Sauer; C Bert; D Giantsoudi; S Corradini; V Batista
Journal:  Radiat Oncol       Date:  2020-07-31       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.